Reparixin - CAS# 266359-83-5 10125 Odanacatib (30 mg/kg

Odanacatib (30 mg/kg

TC-DAPK 6 is a potent

Formula: C18H14Cl2N2O2

It was developed as a replacement drug to combat bacteria that had acquired antibiotic resistance to commonly used antibiotics

Formula: C9H12N2O5

Reparixin - CAS# 266359-83-5 10125 Odanacatib (30 mg/kgReparixin is an inhibitor of CXCR2 function, which attenuates inflammatory responses and promotes recovery of function after traumatic lesion to the spinal cord. In a human breast cancer cell line, both reparixin reduced the number of breast cancer stem cells compared with no treatment. I n mice with primary human breast cancer xenografts, reparixin alone or in combination with docetaxel reduced tumor growth compared with saline control. The